Clinical Trial Update: Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating tailored treatment for elderly patients with newly diagnosed primary central nervous system lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Primary Central Nervous System Lymphoma | Phase 2 | Status: COMPLETED